Stock Analysts

Alkermes (ALKS) Q3 Loss in Line, Sales Miss; ’16 View Intact

Alkermes plc ALKS reported a loss of 25 cents per share (including the impact of share-based compensation expense) in the third quarter of 2016, in line with the Zacks Consensus Estimate. The reported loss was, however, narrower than the year-ago tally of 43 cents. Alkermes reported revenues of $180.2 million in the third quarter of 2016, up 18.1% year over year […]

Stock Analysts

Leisure Stocks Earnings Releases on Nov 4: MSG, LIND, RDI

We are well into the second half of the Q3 earning season and the widely diversified Consumer Discretionary sector has grabbed much of the attention. According to the latest Earnings Outlook , 54.3% of the Consumer Discretionary companies in the S&P 500 index have already reported their results as of Nov 2. The growth rate for earnings and revenues is 11% and 7.9%, respectively […]

Technicals

Avon (AVP) Stock Up 8% Despite Q3 Earnings & Sales Miss

Avon Products Inc. AVP , leading manufacturer and marketer of beauty and related products, reported adjusted earnings of 2 cents per share for third-quarter 2016 results, which fell a penny short of the Zacks Consensus Earnings Estimate, but fared better than the year ago loss of 11 cents per share. Earnings Estimate Revision: The Zacks Consensus Estimate for 2016 has been unchanged in the last 30 days. […]

Technicals

Why Ariad Pharmaceuticals (ARIA) Might Be a Diamond in the Rough

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach. So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision […]